Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
333.28
+0.77 (+0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
39
40
Next >
Markets Close Lower Again In Up And Down Trading Day; Nasdaq Falls 1.5%
March 03, 2022
U.S. indices had a mixed day of trading, with stocks experiencing continued volatility amid the Russia-Ukraine conflict. The conflict has continued...
Via
Benzinga
36 Stocks To Watch After Biden's First State of The Union Address
March 02, 2022
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped...
Via
Benzinga
Amgen's Tezspire Reduces Annualized Exacerbation Rate In Severe Asthma Patients
February 28, 2022
Amgen Inc (NASDAQ: AMGN) shared results from a pooled post-hoc analysis of the NAVIGATOR Phase 3 and PATHWAY Phase 2b trials of Tezspire (tezepelumab-ekko) in broad...
Via
Benzinga
What 10 Analyst Ratings Have To Say About Amgen
February 09, 2022
Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:
Via
Benzinga
Amgen Stock Remains In Limbo As Its Biggest Product Flounders
February 07, 2022
Sales of Enbrel fell, in part, because Amgen's Otezla gained a new approval.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
A Bullish Sign Appears On Amgen's Chart
February 23, 2022
If history is any guide, there may be good fortune ahead for shares of Amgen (NASDAQ:AMGN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could...
Via
Benzinga
Apple And Nike Lead The Dow Jones Lower Amid Russia-Ukraine Tensions
February 22, 2022
U.S. indices traded lower Tuesday after Russia ordered troops into separatist regions of Ukraine after recognizing the Donetsk and Luhansk regions ...
Via
Benzinga
"Prudent" Biotech Bets
February 20, 2022
Here, we review two recommended biotechnology stocks following the release of their latest earnings reports. Let's take a look.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
February 17, 2022
Can the formerly red-hot biotech segment return to its previous glory?
Via
Investor's Business Daily
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...
Via
Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
February 15, 2022
Amgen Inc (NASDAQ: AMGN) announced the presentation of efficacy and safety data from the CodeBreaK 100 Phase 1/2 trial in KRAS G12C-mutated advanced...
Via
Benzinga
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.
Via
Talk Markets
7 Defensive Growth Stocks to Buy for February
February 14, 2022
These seven top defensive growth stocks are among the best options for investors looking for growth, but with a risk-off perspective.
Via
InvestorPlace
This Is What Whales Are Betting On Amgen
February 11, 2022
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Dow Sheds Over 500 Points as Inflation Fears Swirl
February 10, 2022
The Dow finished 526 points lower, snapping its three-day win streak as the 10-year Treasury yield surged above 2%.
Via
Talk Markets
Dow Extends Win Streak Ahead of Key Inflation Data
February 09, 2022
The Dow added 305 points on Wednesday, extending its win streak for a third-straight session, as investors unpacked more upbeat earnings reports. The Nasdaq and S&P 500 also walked away with solid...
Via
Talk Markets
10 Biggest Price Target Changes For Wednesday
February 09, 2022
Cowen & Co. cut the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $2,250 to $1,950. Chipotle shares rose 6.1% to $1,549.97 in pre-market trading.
Via
Benzinga
Dow Brushes Off Rising Bond Yields With Triple-Digit Win
February 08, 2022
Despite inflationary fears driving the 10-year Treasury note to its highest level since November 2019, stocks managed to walk away with wins on Tuesday.
Via
Talk Markets
AMD And Pinduoduo Lead The Nasdaq Higher
February 08, 2022
U.S. indices finished higher Tuesday as traders and investors weighed recent earnings and watch for inflation data later this week.
Via
Benzinga
What Are Whales Doing With Amgen
February 08, 2022
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Amgen's Q4 Sales Remain Flat As Its Biggest Product Flounders
February 08, 2022
Amgen Inc's (NASDAQ: AMGN) Q4 revenues incr
Via
Benzinga
Failed Experiments
February 08, 2022
Amazon had around $470 billion in revenue in 2021. Was it worth it to pick up $14.5 billion in revenue in online grocery sales?
Via
Talk Markets
What's Going On With Amgen Stock During Today's After-Hours Session
February 07, 2022
Shares of Amgen Inc. (NASDAQ: AMGN) stepped higher following the release of its Q4 earnings report showing an EPS beat and a slight miss on sales. The company reported, on a GAAP...
Via
Benzinga
Amgen: Q4 Earnings Insights
February 07, 2022
Amgen (NASDAQ:AMGN) reported its Q4 earnings results on Monday, February 7, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amgen beat estimated earnings by 5.83%,...
Via
Benzinga
(AMGN) - Analyzing Amgen Inc's Short Interest
February 07, 2022
Amgen Inc's (NASDAQ:AMGN) short percent of float has risen 5.91% since last its last report. The company recently reported that it has 12.07 million shares sold short, which is 2....
Via
Benzinga
Picking Up Steam
February 07, 2022
Friday’s close marked 23 trading days since the S&P 500’s last closing record high, and during that span, the S&P 500 is down 6.2%.
Via
Talk Markets
A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%
February 07, 2022
U.S. stock futures traded lower in early pre-market trade after the Nasdaq jumped more than 200 points in the previous session.
Via
Talk Markets
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.